SCHEMBL20150343

SCHEMBL20150343

Cc1ccccc1-c1ccc2c(c1)c1cc(-c3ccccc3C)ccc1n2-c1cc(C#N)ccc1-c1nc(-c2ccccc2)nc(-c2ccccc2)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 10/20 0.37
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
CYP1A2 P05177 4/20 0.36
CYP3A4 P08684 4/20 0.36
ALDH1A1 P00352 3/20 0.36
CYP2C19 P33261 3/20 0.36
CLK4 Q9HAZ1 3/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP2D6 P10635 2/20 0.36
TSHR P16473 2/20 0.36
LMNA P02545 1/20 0.36
CYP2C9 P11712 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ABCB1 P08183 4/20 0.36
PTGER4 P35408 1/20 0.35
AR P10275 1/20 0.35
MAPK1 P28482 1/20 0.34
NR3C1 P04150 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20150342 0.97 PTGER4 (0.39) ABCG2CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL22243173 0.92 PTGER4 (0.39) ABCG2CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL20114552 0.92 ABCG2 (0.36) ABCG2CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL21090885 0.92 ABCG2 (0.37) ABCG2CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL20115012 0.92 ABCG2 (0.37) ABCG2CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL22243009 0.90 PTGER4 (0.38) ABCG2CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL21741939 0.90 PTGER4 (0.35) ABCG2CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL20114634 0.90 CYP1A2 (0.41) ABCG2CYP1A2CYP3A4ALDH1A1CYP2C19
SCHEMBL20114558 0.89 PTGER4 (0.38) ABCG2CYP11B1CYP11B2CYP1A2CYP3A4
SCHEMBL21741929 0.89 ABCG2 (0.40) ABCG2CYP11B1CYP11B2CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices CYNORA GMBH (DE) 2019-09-24 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2018-05-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180134686-A1 ORGANIC MOLECULES, ESPECIALLY FOR USE IN ORGANIC OPTOELECTRONIC DEVICES OR10J3, EPCAM, F12 ABCG2 2585/4885CYP11B1 1765/4885CYP11B2 1259/4885
US-10421746-B2 Organic molecules, especially for use in organic optoelectronic devices OR10J3, EPCAM, F12 ABCG2 2585/4885CYP11B1 1765/4885CYP11B2 1259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.